首页 | 本学科首页   官方微博 | 高级检索  
     

55例清开灵注射液不良反应文献分析
引用本文:施振国,尹红. 55例清开灵注射液不良反应文献分析[J]. 中国药物应用与监测, 2009, 6(6): 361-363
作者姓名:施振国  尹红
作者单位:解放军总医院药品保障中心,北京,100853
摘    要:目的:探讨清开灵注射液所致不良反应(ADR)的规律和特点,为临床安全用药提供参考。方法:2000—2009年国内医药期刊报道的清开灵注射液所致ADR性别与年龄分布、既往过敏史、ADR出现时间、原患疾病、用药情况、主要临床表现、抢救措施及预后等进行统计分析。结果:55例ADR中,男、女患者分别占58.18%和41.82%,儿童和青壮年发生比例相对较高(63.63%),ADR大多发生在用药30min内,主要以全身性损害(61.82%)和皮肤及其附件损害(16.36%)为主。过敏性休克发生例次较多。结论:临床应当严格对清开灵注射液的使用,重视过敏性休克反应。

关 键 词:清开灵注射液  不良反应  文献分析

Analysis of 55 Adverse Drug Reactions Induced by Qingkailing Injection
SHI Zhen-guo,YIN Hong. Analysis of 55 Adverse Drug Reactions Induced by Qingkailing Injection[J]. , 2009, 6(6): 361-363
Authors:SHI Zhen-guo  YIN Hong
Affiliation:(Department of Pharmaceutical Care, PLA General Hospital, Beijing, 100853)
Abstract:Objective: To discuss the general characteristics of the ADRs induced by qingkailing injection, and provide guideline for rational drug use in clinic. Methods: 55 ADR cases induced by qingkailing injection reported in domestic medical journals from 2000 to 2009 were collected and statistically analyzed in respect of the distribution of gender and age, the condition of anaphylaxis, occurrence time of ADRs, the primary diseases, utilization of drugs, main clinical manifestations, rescuing measures and prognosis. Results: Among the 55 ADR cases, the proportions of the male and female patients were 58.18% and 41.82%, and the proportions of ADR that happened to children and young were relatively high (63.63%). Most of the ADR induced by qingkailing injection occurred within 30 minutes after medication. The disorders of the whole body and skin (61.82%) and appendants damage (16.36%) occupied mostly in ADR cases. The incidence of allergic shock was high. Conclusion: Doctor should use the medicine strictly, and pay more attention to the anaphylactic shock. The monitoring of the medicine should be emphasized to reduce the incidence of ADRs.
Keywords:Qingkailing injection  Adverse drug reaction  Literature analysis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号